VERVE THERAPEUTICS INC. - COMMON STOCK
7.4100
30-1月-25 16:45:00
15 分の遅延
株式
-0.2900
-3.77%
本日の幅
7.3850 - 7.9600
ISIN
N/A
ソース
NASDAQ
-
Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference
29 1 2025 07:00:00 提供 Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Pipeline Progress and Anticipated 2025 Milestones
13 1 2025 07:00:00 提供 Nasdaq GlobeNewswire
-
Verve Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
08 1 2025 07:00:00 提供 Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 1 2025 16:05:00 提供 Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
29 11 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results
05 11 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01 11 2024 16:26:49 提供 Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02 10 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 9 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results
08 8 2024 07:00:01 提供 Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02 8 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01 7 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
28 6 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
31 5 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Leadership Update
31 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Verve Therapeutics to Participate in Upcoming Investor Conferences
30 5 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
08 5 2024 07:00:01 提供 Nasdaq GlobeNewswire
-
07 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 5 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
Verve Therapeutics Announces Updates on its PCSK9 Program
02 4 2024 07:00:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >